Burn: Clinical Trials

5 trials for Burn, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 32Completed 2

Follow Burn: new trials by email Literature Review of Burn trials Research Report on Burn

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn
Autologous epidermal cell suspension, Silver sulfadiazine ointment - Burn
Phase 2CompletedSCARM Institute, Tabriz, Iran402019-04-102020-03-18
Vitamin E Supplementation in Burned Patients
Vitamin E - Burn
Phase 2 / Phase 3CompletedThe University of Texas Medical Branch, Galveston272013-02-012026-07-20
Low Dose Ketamine VR Analgesia During Burn Care Procedure
Virtual Reality - Burn
Phase 2CompletedNational Institute of General Medical Sciences (NIGMS)32012-07-012017-09-01
Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns
DGD - Burn
Phase 2CompletedMediWound Ltd362009-12-202021-09-09
Virtual Reality Pain Control During Burn Wound Care
Virtual Reality Distraction - Burn
Phase 2 / Phase 3CompletedNational Institute of General Medical Sciences (NIGMS)1842002-02-012013-04-19

Narrower conditions

Burns (5)  ·  Inflammation (1)

Broader conditions

Wounds and Injuries (5)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Vitamin E (1)  ·  alpha-Tocopherol (1)  ·  alpha-tocopheryl nicotinate (1)

Sponsors

National Institute of General Medical Sciences (NIGMS) (2)  ·  MediWound Ltd (1)  ·  SCARM Institute, Tabriz, Iran (1)  ·  The University of Texas Medical Branch, Galveston (1)

Countries

United States (3)  ·  India (1)  ·  Iran (1)  ·  Israel (1)

Top investigators

David R Patterson, Ph.D. (1)  ·  David R. Patterson, Ph.D. (1)  ·  Linda E Sousse, PhD, MBA (1)  ·  Lior Rosenberg, MD (1)  ·  Mohamad Reza Ranjkesh, MD, Dermatologist (1)  ·  Perenlei Enkhbaatar, MD, PhD (1)

Results publications

PMID 24616577, PMID 25426401, PMID 26419871, PMID 26706649

NIH funding

R01GM042725 (1)